Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

Javeed Iqbal, Timothy Charles Greiner, K. Patel, Bhavana J Dave, Lynette M Smith, J. Ji, G. Wright, W. G. Sanger, D. L. Pickering, S. Jain, D. E. Horsman, Y. Shen, Kai Fu, D. D. Weisenburger, C. P. Hans, E. Campo, R. D. Gascoyne, A. Rosenwald, E. S. Jaffe, J. DelabieL. Rimsza, G. Ott, H. K. Müller-Hermelink, J. M. Connors, Julie Marie Vose, T. McKeithan, L. M. Staudt, W. C. Chan

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Gene expression profiling of diffuse large B-cell lymphoma (DLBCL) has revealed biologically and prognostically distinct subgroups: germinal center B-cell-like (GCB), activated B-cell-like (ABC) and primary mediastinal (PM) DLBCL. The BCL6 gene is often translocated and/or mutated in DLBCL. Therefore, we examined the BCL6 molecular alterations in these DLBCL subgroups, and their impact on BCL6 expression and BCL6 target gene repression. BCL6 translocations at the major breakpoint region (MBR) were detected in 25 (18.8%) of 133 DLBCL cases, with a higher frequency in the PM (33%) and ABC (24%) subgroups than in the GCB (10%) subgroup. Translocations at the alternative breakpoint region (ABR) were detected in five (6.4%) of 78 DLBCL cases, with three cases in ABC and one case each in the GCB and the unclassifiable subgroups. The translocated cases involved IgH and non-IgH partners in about equal frequency and were not associated with different levels of BCL6 mRNA and protein expression. BCL6 mutations were detected in 61% of DLBCL cases, with a significantly higher frequency in the GCB and PM subgroups (>70%) than in the ABC subgroup (44%). Exon-1 mutations were mostly observed in the GCB subgroup. The repression of known BCL6 target genes correlated with the level of BCL6 mRNA and protein expression in GCB and ABC subgroups but not with BCL6 translocation and intronic mutations. No clear inverse correlation between BCL6 expression and p53 expression was observed. Patients with higher BCL6 mRNA or protein expression had a significantly better overall survival. The biological role of BCL6 in translocated cases where repression of known target genes is not demonstrated is intriguing and warrants further investigation.

Original languageEnglish (US)
Pages (from-to)2332-2343
Number of pages12
JournalLeukemia
Volume21
Issue number11
DOIs
StatePublished - Nov 2007

Fingerprint

Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Germinal Center
Messenger RNA
Mutation
Genes
Proteins
Gene Expression Profiling
Exons

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. / Iqbal, Javeed; Greiner, Timothy Charles; Patel, K.; Dave, Bhavana J; Smith, Lynette M; Ji, J.; Wright, G.; Sanger, W. G.; Pickering, D. L.; Jain, S.; Horsman, D. E.; Shen, Y.; Fu, Kai; Weisenburger, D. D.; Hans, C. P.; Campo, E.; Gascoyne, R. D.; Rosenwald, A.; Jaffe, E. S.; Delabie, J.; Rimsza, L.; Ott, G.; Müller-Hermelink, H. K.; Connors, J. M.; Vose, Julie Marie; McKeithan, T.; Staudt, L. M.; Chan, W. C.

In: Leukemia, Vol. 21, No. 11, 11.2007, p. 2332-2343.

Research output: Contribution to journalArticle

Iqbal, J, Greiner, TC, Patel, K, Dave, BJ, Smith, LM, Ji, J, Wright, G, Sanger, WG, Pickering, DL, Jain, S, Horsman, DE, Shen, Y, Fu, K, Weisenburger, DD, Hans, CP, Campo, E, Gascoyne, RD, Rosenwald, A, Jaffe, ES, Delabie, J, Rimsza, L, Ott, G, Müller-Hermelink, HK, Connors, JM, Vose, JM, McKeithan, T, Staudt, LM & Chan, WC 2007, 'Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma', Leukemia, vol. 21, no. 11, pp. 2332-2343. https://doi.org/10.1038/sj.leu.2404856
Iqbal, Javeed ; Greiner, Timothy Charles ; Patel, K. ; Dave, Bhavana J ; Smith, Lynette M ; Ji, J. ; Wright, G. ; Sanger, W. G. ; Pickering, D. L. ; Jain, S. ; Horsman, D. E. ; Shen, Y. ; Fu, Kai ; Weisenburger, D. D. ; Hans, C. P. ; Campo, E. ; Gascoyne, R. D. ; Rosenwald, A. ; Jaffe, E. S. ; Delabie, J. ; Rimsza, L. ; Ott, G. ; Müller-Hermelink, H. K. ; Connors, J. M. ; Vose, Julie Marie ; McKeithan, T. ; Staudt, L. M. ; Chan, W. C. / Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. In: Leukemia. 2007 ; Vol. 21, No. 11. pp. 2332-2343.
@article{9c62c99a9deb480e890a41dc341dba5e,
title = "Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma",
abstract = "Gene expression profiling of diffuse large B-cell lymphoma (DLBCL) has revealed biologically and prognostically distinct subgroups: germinal center B-cell-like (GCB), activated B-cell-like (ABC) and primary mediastinal (PM) DLBCL. The BCL6 gene is often translocated and/or mutated in DLBCL. Therefore, we examined the BCL6 molecular alterations in these DLBCL subgroups, and their impact on BCL6 expression and BCL6 target gene repression. BCL6 translocations at the major breakpoint region (MBR) were detected in 25 (18.8{\%}) of 133 DLBCL cases, with a higher frequency in the PM (33{\%}) and ABC (24{\%}) subgroups than in the GCB (10{\%}) subgroup. Translocations at the alternative breakpoint region (ABR) were detected in five (6.4{\%}) of 78 DLBCL cases, with three cases in ABC and one case each in the GCB and the unclassifiable subgroups. The translocated cases involved IgH and non-IgH partners in about equal frequency and were not associated with different levels of BCL6 mRNA and protein expression. BCL6 mutations were detected in 61{\%} of DLBCL cases, with a significantly higher frequency in the GCB and PM subgroups (>70{\%}) than in the ABC subgroup (44{\%}). Exon-1 mutations were mostly observed in the GCB subgroup. The repression of known BCL6 target genes correlated with the level of BCL6 mRNA and protein expression in GCB and ABC subgroups but not with BCL6 translocation and intronic mutations. No clear inverse correlation between BCL6 expression and p53 expression was observed. Patients with higher BCL6 mRNA or protein expression had a significantly better overall survival. The biological role of BCL6 in translocated cases where repression of known target genes is not demonstrated is intriguing and warrants further investigation.",
author = "Javeed Iqbal and Greiner, {Timothy Charles} and K. Patel and Dave, {Bhavana J} and Smith, {Lynette M} and J. Ji and G. Wright and Sanger, {W. G.} and Pickering, {D. L.} and S. Jain and Horsman, {D. E.} and Y. Shen and Kai Fu and Weisenburger, {D. D.} and Hans, {C. P.} and E. Campo and Gascoyne, {R. D.} and A. Rosenwald and Jaffe, {E. S.} and J. Delabie and L. Rimsza and G. Ott and M{\"u}ller-Hermelink, {H. K.} and Connors, {J. M.} and Vose, {Julie Marie} and T. McKeithan and Staudt, {L. M.} and Chan, {W. C.}",
year = "2007",
month = "11",
doi = "10.1038/sj.leu.2404856",
language = "English (US)",
volume = "21",
pages = "2332--2343",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

AU - Iqbal, Javeed

AU - Greiner, Timothy Charles

AU - Patel, K.

AU - Dave, Bhavana J

AU - Smith, Lynette M

AU - Ji, J.

AU - Wright, G.

AU - Sanger, W. G.

AU - Pickering, D. L.

AU - Jain, S.

AU - Horsman, D. E.

AU - Shen, Y.

AU - Fu, Kai

AU - Weisenburger, D. D.

AU - Hans, C. P.

AU - Campo, E.

AU - Gascoyne, R. D.

AU - Rosenwald, A.

AU - Jaffe, E. S.

AU - Delabie, J.

AU - Rimsza, L.

AU - Ott, G.

AU - Müller-Hermelink, H. K.

AU - Connors, J. M.

AU - Vose, Julie Marie

AU - McKeithan, T.

AU - Staudt, L. M.

AU - Chan, W. C.

PY - 2007/11

Y1 - 2007/11

N2 - Gene expression profiling of diffuse large B-cell lymphoma (DLBCL) has revealed biologically and prognostically distinct subgroups: germinal center B-cell-like (GCB), activated B-cell-like (ABC) and primary mediastinal (PM) DLBCL. The BCL6 gene is often translocated and/or mutated in DLBCL. Therefore, we examined the BCL6 molecular alterations in these DLBCL subgroups, and their impact on BCL6 expression and BCL6 target gene repression. BCL6 translocations at the major breakpoint region (MBR) were detected in 25 (18.8%) of 133 DLBCL cases, with a higher frequency in the PM (33%) and ABC (24%) subgroups than in the GCB (10%) subgroup. Translocations at the alternative breakpoint region (ABR) were detected in five (6.4%) of 78 DLBCL cases, with three cases in ABC and one case each in the GCB and the unclassifiable subgroups. The translocated cases involved IgH and non-IgH partners in about equal frequency and were not associated with different levels of BCL6 mRNA and protein expression. BCL6 mutations were detected in 61% of DLBCL cases, with a significantly higher frequency in the GCB and PM subgroups (>70%) than in the ABC subgroup (44%). Exon-1 mutations were mostly observed in the GCB subgroup. The repression of known BCL6 target genes correlated with the level of BCL6 mRNA and protein expression in GCB and ABC subgroups but not with BCL6 translocation and intronic mutations. No clear inverse correlation between BCL6 expression and p53 expression was observed. Patients with higher BCL6 mRNA or protein expression had a significantly better overall survival. The biological role of BCL6 in translocated cases where repression of known target genes is not demonstrated is intriguing and warrants further investigation.

AB - Gene expression profiling of diffuse large B-cell lymphoma (DLBCL) has revealed biologically and prognostically distinct subgroups: germinal center B-cell-like (GCB), activated B-cell-like (ABC) and primary mediastinal (PM) DLBCL. The BCL6 gene is often translocated and/or mutated in DLBCL. Therefore, we examined the BCL6 molecular alterations in these DLBCL subgroups, and their impact on BCL6 expression and BCL6 target gene repression. BCL6 translocations at the major breakpoint region (MBR) were detected in 25 (18.8%) of 133 DLBCL cases, with a higher frequency in the PM (33%) and ABC (24%) subgroups than in the GCB (10%) subgroup. Translocations at the alternative breakpoint region (ABR) were detected in five (6.4%) of 78 DLBCL cases, with three cases in ABC and one case each in the GCB and the unclassifiable subgroups. The translocated cases involved IgH and non-IgH partners in about equal frequency and were not associated with different levels of BCL6 mRNA and protein expression. BCL6 mutations were detected in 61% of DLBCL cases, with a significantly higher frequency in the GCB and PM subgroups (>70%) than in the ABC subgroup (44%). Exon-1 mutations were mostly observed in the GCB subgroup. The repression of known BCL6 target genes correlated with the level of BCL6 mRNA and protein expression in GCB and ABC subgroups but not with BCL6 translocation and intronic mutations. No clear inverse correlation between BCL6 expression and p53 expression was observed. Patients with higher BCL6 mRNA or protein expression had a significantly better overall survival. The biological role of BCL6 in translocated cases where repression of known target genes is not demonstrated is intriguing and warrants further investigation.

UR - http://www.scopus.com/inward/record.url?scp=35548935663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548935663&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404856

DO - 10.1038/sj.leu.2404856

M3 - Article

C2 - 17625604

AN - SCOPUS:35548935663

VL - 21

SP - 2332

EP - 2343

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 11

ER -